Health Benefits and Side Effects of Short-Chain Fatty Acids DOI Creative Commons
Ruo-Gu Xiong, Dan-Dan Zhou, Si-Xia Wu

et al.

Foods, Journal Year: 2022, Volume and Issue: 11(18), P. 2863 - 2863

Published: Sept. 15, 2022

The gut microbiota and their metabolites could play an important role in health diseases of human beings. Short-chain fatty acids (SCFAs) are mainly produced by microbiome fermentation dietary fiber also be bacteria the skin vagina. Acetate, propionate, butyrate three major SCFAs, bioactivities have been widely studied. SCFAs many benefits, such as anti-inflammatory, immunoregulatory, anti-obesity, anti-diabetes, anticancer, cardiovascular protective, hepatoprotective, neuroprotective activities. This paper summarizes benefits side effects with a special attention paid to mechanisms action. provides better support for people eating well ways developed into functional food prevent diseases.

Language: Английский

Interaction between microbiota and immunity in health and disease DOI Creative Commons

Danping Zheng,

Timur Liwinski, Eran Elinav

et al.

Cell Research, Journal Year: 2020, Volume and Issue: 30(6), P. 492 - 506

Published: May 20, 2020

Abstract The interplay between the commensal microbiota and mammalian immune system development function includes multifold interactions in homeostasis disease. microbiome plays critical roles training of major components host’s innate adaptive system, while orchestrates maintenance key features host-microbe symbiosis. In a genetically susceptible host, imbalances microbiota-immunity under defined environmental contexts are believed to contribute pathogenesis multitude immune-mediated disorders. Here, we review microbiome-immunity crosstalk their health disease, providing examples molecular mechanisms orchestrating these intestine extra-intestinal organs. We highlight aspects current knowledge, challenges limitations achieving causal understanding host immune-microbiome interactions, as well impact on diseases, discuss how insights may translate towards future microbiome-targeted therapeutic interventions.

Language: Английский

Citations

2772

Diversity, Mechanisms, and Significance of Macrophage Plasticity DOI
Massimo Locati, Graziella Curtale, Alberto Mantovani

et al.

Annual Review of Pathology Mechanisms of Disease, Journal Year: 2019, Volume and Issue: 15(1), P. 123 - 147

Published: Sept. 18, 2019

Macrophages are a diverse set of cells present in all body compartments. This diversity is imprinted by their ontogenetic origin (embryonal versus adult bone marrow-derived cells); the organ context; activation or deactivation various signals contexts microbial invasion, tissue damage, and metabolic derangement; polarization adaptive T cell responses. Classic responses macrophages include tolerance, priming, wide spectrum states, including M1, M2, M2-like. Moreover, can retain long-term imprinting encounters (trained innate immunity). Single-cell analysis mononuclear phagocytes health disease has added new dimension to our understanding macrophage differentiation activation. Epigenetic landscapes, transcription factors, microRNA networks underlie adaptability different environmental cues. Macrophage plasticity, an essential component chronic inflammation, its involvement human diseases, most notably cancer, discussed here as paradigm.

Language: Английский

Citations

1494

The gut-liver axis in liver disease: Pathophysiological basis for therapy DOI Creative Commons
Agustı́n Albillos, Andrea De Gottardi, María Rescigno

et al.

Journal of Hepatology, Journal Year: 2019, Volume and Issue: 72(3), P. 558 - 577

Published: Oct. 15, 2019

The gut-liver axis refers to the bidirectional relationship between gut and its microbiota, liver, resulting from integration of signals generated by dietary, genetic environmental factors. This reciprocal interaction is established portal vein which enables transport gut-derived products directly liver feedback route bile antibody secretion intestine. intestinal mucosal vascular barrier functional anatomical structure that serves as a playground for interactions limiting systemic dissemination microbes toxins while allowing nutrients access circulation reach liver. control microbial communities critical maintaining homeostasis axis, part this communication shapes communities. Alcohol disrupts at multiple interconnected levels, including microbiome, mucus barrier, epithelial level antimicrobial peptide production, increases exposure proinflammatory environment Growing evidence indicates pathogenetic role microbe-derived metabolites, such trimethylamine, secondary acids, short-chain fatty acids ethanol, in pathogenesis non-alcoholic disease. Cirrhosis itself associated with profound alterations microbiota damage different levels defence epithelial, immune barriers. relevance severe disturbance cirrhosis has been linked translocation live bacteria, bacterial infections disease progression. identification elements primarily damaged each chronic offers possibilities intervention. Beyond antibiotics, upcoming therapies centred on include new generations probiotics, metabolites (postbiotics), faecal transplantation, carbon nanoparticles. FXR-agonists target both are currently being tested diseases. Finally, synthetic biotic medicines, phages specific bacteria or create physical barriers offer therapeutic approaches.

Language: Английский

Citations

1411

Ulcerative colitis DOI
Taku Kobayashi, Britta Siegmund, Catherine Le Berre

et al.

Nature Reviews Disease Primers, Journal Year: 2020, Volume and Issue: 6(1)

Published: Sept. 10, 2020

Language: Английский

Citations

1065

SCFA: mechanisms and functional importance in the gut DOI Open Access
Camille Martin‐Gallausiaux, Ludovica Marinelli, Hervé M. Blottière

et al.

Proceedings of The Nutrition Society, Journal Year: 2020, Volume and Issue: 80(1), P. 37 - 49

Published: April 2, 2020

In recent years, the importance of gut microbiota in human health has been revealed and many publications have highlighted its role as a key component physiology. Owing to use modern sequencing approaches, characterisation microbiome healthy individuals disease demonstrated disturbance microbiota, or dysbiosis, associated with pathological conditions. The establishes symbiotic crosstalk their host: commensal microbes benefit from nutrient-rich environment provided by produces hundreds proteins metabolites that modulate functions host, including nutrient processing, maintenance energy homoeostasis immune system development. Many bacteria-derived originate dietary sources. Among them, an important attributed derived bacterial fermentation fibres, namely SCFA linking host nutrition intestinal maintenance. are fuels for epithelial cells (IEC) regulate IEC through different mechanisms proliferation, differentiation well subpopulations such enteroendocrine cells, impact motility strengthen barrier metabolism. Recent findings show SCFA, particular butyrate, also immuno-modulatory functions. this review, we discuss on immunity consequently health.

Language: Английский

Citations

924

Human Monocyte Subsets and Phenotypes in Major Chronic Inflammatory Diseases DOI Creative Commons
Theodore S. Kapellos, Lorenzo Bonaguro, Ioanna D. Gemünd

et al.

Frontiers in Immunology, Journal Year: 2019, Volume and Issue: 10

Published: Aug. 30, 2019

Human monocytes are divided in three major populations; classical (CD14+CD16-), non-classical (CD14dimCD16+), and intermediate (CD14+CD16+). Each of these subsets is distinguished from each other by the expression distinct surface markers their functions homeostasis disease. In this review, we discuss most up-to-date phenotypic classification human that has been greatly aided application novel single-cell transcriptomic mass cytometry technologies. Furthermore, shed light on role plastic immune cells already recognized emerging chronic diseases, such as obesity, atherosclerosis, obstructive pulmonary disease, lung fibrosis, cancer, Alzheimer's Our aim to provide an insight into contribution progression diseases highlight candidacy potential therapeutic cell targets.

Language: Английский

Citations

693

Western Diet and the Immune System: An Inflammatory Connection DOI Creative Commons
Anette Christ, Mario A. Lauterbach, Eicke Latz

et al.

Immunity, Journal Year: 2019, Volume and Issue: 51(5), P. 794 - 811

Published: Nov. 1, 2019

Language: Английский

Citations

672

Ulcerative colitis DOI
Catherine Le Berre, Sailish Honap, Laurent Peyrin‐Biroulet

et al.

The Lancet, Journal Year: 2023, Volume and Issue: 402(10401), P. 571 - 584

Published: Aug. 1, 2023

Language: Английский

Citations

567

The immunology of sepsis DOI Creative Commons
Tom van der Poll, Manu Shankar‐Hari, W. Joost Wiersinga

et al.

Immunity, Journal Year: 2021, Volume and Issue: 54(11), P. 2450 - 2464

Published: Nov. 1, 2021

Language: Английский

Citations

549

Targeting immune cell circuits and trafficking in inflammatory bowel disease DOI Open Access
Markus F. Neurath

Nature Immunology, Journal Year: 2019, Volume and Issue: 20(8), P. 970 - 979

Published: June 24, 2019

Language: Английский

Citations

523